6 Multibagger Stocks That Soared After FIIs Corrected Their Mistakes

While Foreign Institutional Investors (FIIs) have been viewed as the primary bears on Dalal Street, a closer look at the data reveals a different story of selective accumulation. In several instances, foreign investors realized miscalculations in their previous selling streaks and quietly pivoted, leading to massive wealth creation for early movers.

The FII U-Turn: From Selling to Selective Buying

According to data from ACE Equity, a specific group of six stocks saw FIIs reverse their positions in the March quarter after two consecutive quarters of selling. This institutional course correction acted as a massive catalyst, turning these stocks into multibaggers.

The most striking example is Bajaj Consumer Care, which delivered a staggering 265% return over the past year. FIIs had been systematically trimming their holdings from 10.95% in June 2025 to 9.7% by December 2025. However, they aggressively ramped up their stake to 16.59% in the March 2026 quarter, sending the stock price from Rs 169.8 to Rs 619.7.

Analysis of the Six Multibagger Performers

Beyond Bajaj Consumer Care, several other companies saw significant price appreciation following FII re-entry:

  • Acutaas Chemicals: FII shareholding grew from 16.94% (June 2025) to 19.48% (March 2026), driving a 187% price surge from Rs 1,130.75 to Rs 3,248.45.
  • SML Mahindra: Despite a dramatic dip in FII holding to just 0.61% in December, a subsequent pivot led to a 124.75% return.
  • Dee Development Engineers: A marginal increase in FII holding from 0.81% to 0.99% accompanied a 119% jump in stock price (from Rs 309.8 to Rs 677.65).
  • United Foodbrands: Following a low point in September 2025, measured FII accumulation helped the stock rise 112% to Rs 672.
  • RateGain Travel Technologies: FII ownership rebounded from a low of 4.97% to 5.35%, resulting in a 102% gain, with the stock reaching Rs 873.25.

Diverse Market Outlooks: What Experts Predict Next

As the market navigates shifting macroeconomic narratives, brokerage houses and fund managers are offering divergent strategies for the next phase of growth.

Nuvama’s strategy team focuses on demand dynamics, favoring high dividend-yield sectors and exporters. They remain overweight on consumer, cement, chemicals, IT, private banks, and pharma, while staying underweight on industrials and metals.

In contrast, JM Financial suggests a defensive tilt due to high crude prices and rupee weakness. They recommend repositioning toward pharma, healthcare, and oil and gas, while remaining cautious on banks and IT services due to weak demand visibility.

Tata Mutual Fund maintains a bullish stance on large caps, anticipating that a potential US slowdown could benefit emerging market flows and boost Indian corporate earnings in FY27. Meanwhile, Bandhan AMC’s Manish Gunwani identifies small caps as the most attractive space for a three-to-five-year horizon, specifically highlighting manufacturing, defence, and energy security infrastructure.

Key Takeaways

  • Institutional Reversals: Selective FII re-entry in the March quarter acted as a powerful catalyst for stocks like Bajaj Consumer Care (up 265%) and Acutaas Chemicals (up 187%).
  • Divergent Strategies: While some analysts favor defensive sectors like Pharma and Healthcare, others are looking toward large-cap stability or small-cap growth in manufacturing and defence.
  • Macro Sensitivity: Future market direction remains highly dependent on US economic trends, crude oil prices, and the stability of the Indian Rupee.